Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Biohaven Therapeutics Ltd.
*MAILING ADDRESS
215 Church Street
*CITY
New Haven
*STATE
(Required for U.S. applicants)
Connecticut
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
06510
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
limited company (ltd.)
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED
British Virgin Islands
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
001
*IDENTIFICATION
Binding compounds for laboratory and research use, namely, compounds having affinity to bind endogenous antibodies, antibody fragments,
peptides, proteins, enzymes, lipids, carbohydrates, nucleic acids, or complexes in humans or animals; compounds in the nature of multifunctional molecules to promote antibody recruitment and immune
system cells; and compounds for the preparation of multifunctional molecules to promote antibody recruitment for use in the treatment of autoimmune disorders, inflammatory diseases and conditions,
metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders.
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
005
*IDENTIFICATION
Biomedical binding compounds for pharmaceutical or medical use, namely, compounds having affinity to bind endogenous antibodies, antibody
fragments, peptides, proteins, enzymes, lipids, carbohydrates, nucleic acids, or complexes in humans or animals; compounds in the nature of multifunctional molecules to promote antibody recruitment
and immune system cells; and compounds for the preparation of multifunctional molecules to promote antibody recruitment for use in the treatment of autoimmune disorders, inflammatory diseases and
conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders.
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
042
*IDENTIFICATION
Research and development in the field of binding compounds for pharmaceutical and medical purposes.
FILING BASIS
SECTION 1(b)
ATTORNEY INFORMATION
NAME
Monica Riva Talley
ATTORNEY DOCKET NUMBER
4501.0700000
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Sterne, Kessler, Goldstein & Fox P.L.L.C.
STREET
1100 New York Avenue, N.W.
CITY
Washington
STATE
District of Columbia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
20005
PHONE
202-371-2600
FAX
202-371-2540
EMAIL ADDRESS
tm@sternekessler.com
OTHER APPOINTED ATTORNEY
Tracy-Gene G. Durkin, Dana N. Justus, Shana L. Olson, Ivy Clarice Estoesta and Lauriel F. Dalier
Attorney of Record, Member of Virginia and Washington, DC Bars
SIGNATORY'S PHONE NUMBER
202-371-2600
DATE SIGNED
02/04/2021
SIGNATURE METHOD
Sent to third party for signature
PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:90511057
Filing Date:02/04/2021
To the Commissioner for Trademarks:
MARK: UABT (Standard Characters, see mark)
The literal element of the mark consists of UABT. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Biohaven Therapeutics Ltd., a limited company (ltd.) legally organized under the laws of British Virgin Islands, having an address of
215 Church Street
New Haven, Connecticut 06510
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 001: Binding compounds for laboratory and research use, namely, compounds having affinity to bind endogenous antibodies, antibody fragments, peptides, proteins, enzymes,
lipids, carbohydrates, nucleic acids, or complexes in humans or animals; compounds in the nature of multifunctional molecules to promote antibody recruitment and immune system cells; and compounds
for the preparation of multifunctional molecules to promote antibody recruitment for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders,
allergies, cancers, infectious diseases, and neurological disorders.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 005: Biomedical binding compounds for pharmaceutical or medical use, namely, compounds having affinity to bind endogenous antibodies, antibody fragments, peptides, proteins,
enzymes, lipids, carbohydrates, nucleic acids, or complexes in humans or animals; compounds in the nature of multifunctional molecules to promote antibody recruitment and immune system cells; and
compounds for the preparation of multifunctional molecules to promote antibody recruitment for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders,
allergies, cancers, infectious diseases, and neurological disorders.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 042: Research and development in the field of binding compounds for pharmaceutical and medical purposes.
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Monica Riva Talley. Other appointed attorneys are Tracy-Gene G. Durkin, Dana N. Justus, Shana L. Olson, Ivy Clarice Estoesta and Lauriel F.
Dalier. Monica Riva Talley of Sterne, Kessler, Goldstein & Fox P.L.L.C., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
1100 New York Avenue, N.W.
Washington, District of Columbia 20005
United States
202-371-2600(phone)
202-371-2540(fax)
tm@sternekessler.com
The docket/reference number is 4501.0700000.
Monica Riva Talley submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any
U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $1050 has been submitted with the application, representing payment for 3 class(es).
Declaration
Declaration Signature
Signature: /Monica Riva Talley/ Date: 02/04/2021
Signatory's Name: Monica Riva Talley
Signatory's Position: Attorney of Record, Member of Virginia and Washington, DC Bars
Signatory's Phone Number: 202-371-2600
Signature method: Sent to third party for signature
Payment Sale Number: 90511057
Payment Accounting Date: 02/04/2021
Serial Number: 90511057
Internet Transmission Date: Thu Feb 04 17:11:04 ET 2021
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XXX-20210204171104
764703-90511057-76075a6493d77dfe90fad4ce
905664944163c97afca75b863efc2e4a5961e052
-CC-11032995-20210203152308758323